It was reported that mice with a targeted mutation in the Agpat2 gene developed severe lipodystrophy, affecting both white and brown adipose tissue and causing extreme insulin resistance, diabetes, and hepatic steatosis [31]. This evidence concerns the gene AGPAT2 and Hepatic steatosis.